PANCREATIC CANCER RESEARCH FUND
The charity offers project grants for pancreatic cancer research to researchers in the UK and Ireland.
Objects
4.1 THE CHARITY'S OBJECTS ARE RESTRICTED SPECIFICALLY FOR THE PUBLIC BENEFIT FOR:4.1.1 THE PROMOTION OF RESEARCH INTO THE CONSTITUTION AND PATHOLOGY OF THE PANCREAS AND CAUSES AND TREATMENT OF DISEASE OF THE PANCREAS, WITH PARTICULAR REFERENCE TO PANCREATIC CANCER ON TERMS THAT THE RESULTS OF SUCH RESEARCH ARE PUBLISHED; 4.1.2 THE RELIEF OF PATIENTS SUFFERING FROM PANCREATIC CANCER;4.1.3 THE RELIEF IN CASES OF FINANCIAL NEED OF THE DEPENDANTS OF SUCH PATIENTS OR DECEASED PATIENTS;4.1.4 THE PROMOTION OF SUCH CHARITABLE OBJECTS CONCERNED WITH MEDICAL RESEARCH OR THE RELIEF OF SICKNESS AS THE BOARD SHALL IN ITS ABSOLUTE DISCRETION DETERMINE.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds increased to £5,379,991, driven by a net income of £735,927 which included significant investment returns. The charity is winding down its active grant-making and fundraising operations, with the Chief Executive continuing part-time to administer existing commitments and the Tissue Bank until at least 2027. The trustees confirm that reserves are sufficient to cover the full cost of current awards, minimizing risk as income is expected to decrease.
What the accounts disclose
“The trustees have agreed that research awards will only be offered if the full cost of the award is already available in the charity’s funds. This will minimise risk and ensure continuity for each research project should the charity’s income be dramatically reduced. Reserves, therefore, cover the full cost of awards allocated in each annual award round.” — page 4
Policies the charity declares
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Paying staff
- Risk management
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 30/11/2025
- Volunteers: 5
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 30/11/2024
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 30/11/2023
- Volunteers: 20
- Grant-making is its main activity
Leadership, per the charity’s website
- Jo Hansford — Patron
- Professor Hemant Kocher — Director, PCRF Tissue Bank
Structured financials (annual return, FY ending 30/11/2025)
Trustees
- BRIAN RAPER
- MARGARET BLANKS
- MARGARET BLANKS
- Peter Joseph Michael Blanks
- Stephen Henry Collen
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/11/2025 | £1.5m | £750k |
| 30/11/2024 | £946k | £829k |
| 30/11/2023 | £1.5m | £660k |
| 30/11/2022 | £1.4m | £1.5m |
| 30/11/2021 | £1.4m | £2.2m |
Common questions
Is PANCREATIC CANCER RESEARCH FUND financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds increased to £5,379,991, driven by a net income of £735,927 which included significant investment returns. The charity is winding down its active grant-making and fundraising operations, with the Chief Executive continuing part-time to administer existing commitments and the Tissue Bank until at least 2027. The trustees confirm that reserves are sufficient to cover the full cost of current awards, minimizing risk as income is expected to decrease. Its FY2025 accounts were audited by Grant Harrod Lerman Davis LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE WILL CHARITABLE TRUST | 3 | £40k |
| SIR SAMUEL SCOTT OF YEWS TRUST | 2 | £37k |
| THE INMAN CHARITY | 2 | £24k |
| THE IAN ASKEW CHARITABLE TRUST | 2 | £4k |
| THE MICHAEL AND ANNA WIX CHARITABLE TRUST | 2 | £400 |
| THE FREDDIE GREEN AND FAMILY CHARITABLE FOUNDATION | 1 | £1.9m |
| BREAST CANCER NOW | 1 | £300k |
| WILLIAM ADLINGTON CADBURY CHARITABLE TRUST | 1 | £105k |
Charities like this
- PANCREATIC CANCER UK
- RALPH BATES PANCREATIC CANCER RESEARCH FUND
- PLUM LAYTON CHARITABLE TRUST
- PANCREATIC SOCIETY OF GREAT BRITAIN AND IRELAND
- PANCREATIC CANCER ACTION
- PROSTATE CANCER RESEARCH
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| PANCREATIC CANCER RESEARCH FUND | £1.5m | — | 0 | unclear | — | no doubt |
| PANCREATIC CANCER UK | £14.5m | — | — | above | 38.0% | no doubt |
| RALPH BATES PANCREATIC CANCER RESEARCH FUND | £31k | — | 0 | unclear | — | no doubt |
| PLUM LAYTON CHARITABLE TRUST | £124k | — | 0 | above | — | no doubt |
| PANCREATIC SOCIETY OF GREAT BRITAIN AND IRELAND | £82k | — | 0 | above | — | no doubt |
| PANCREATIC CANCER ACTION | £635k | — | 0 | below | — | noted |